Status:
UNKNOWN
Fluoroscopy Reduction or Elimination in CIED Implants
Lead Sponsor:
Université de Sherbrooke
Conditions:
Bradycardia
Tachycardia, Ventricular
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
CIED implants require different amounts of fluoroscopy; using 3-D mapping systems, these times could be reduced to near zero fluoroscopy. The investigators aim to describe to what extent fluoroscopy t...
Detailed Description
Patients with either brady arrhythmias, tachyarrhythmias, heart failure or primary prevention of sudden death receive a cardiac implantable electronic device (CIED) as a standard of care based on guid...
Eligibility Criteria
Inclusion
- CIED implants
Exclusion
- Patients with an urgent life-threatening indication requiring an urgent CIED implant.
- Patients with known venous system abnormalities (as venous occlusion or abandoned non-accessible leads).
Key Trial Info
Start Date :
January 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 3 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04919733
Start Date
January 3 2020
End Date
March 3 2024
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUS Fleurimont
Sherbrooke, Quebec, Canada, J1H 5N4